#dedoc° blog
Learn about what really matters to people living with diabetes around the world.
The #dedoc° blog features articles and opinion pieces written by our international network of diabetes advocates: the #dedoc° voices. From scientific conferences to the latest diabetes research and technology, from challenges faced by those living with diabetes to global disparities in healthcare — our #dedoc° voices cover it all.
Diabetes advocates wishing to contribute to the #dedoc° blog are welcome to submit a guest post using the link below. Don’t hesitate to get in touch — we love to hear from you, and so do thousands of others!
All opinions are those of the authors.
Contact: blog@dedoc.org
A new era in diabetes care: key takeaways from ISPAD50
“The 50th Anniversary of the ISPAD (International Society for Paediatric and Adolescent Diabetes) Conference, held in Lisbon from October 16-19 2024, was an extraordinary gathering of experts, researchers, healthcare professionals, and advocates, all united by a shared mission: to advance paediatric diabetes care globally,” writes #dedoc° voice Tinotenda Dzikiti.
“Themed “Inclusion & Innovation in Paediatric Diabetes”, this year’s conference marked a significant milestone in ISPAD’s half-century of groundbreaking work, encapsulating decades of progress while laying the foundation for future advancements.”
Diabetes stigma, new technologies and access: learnings from EASD 2024 as a #dedoc° voice
Mark Barone was one of 50 diabetes advocates who attended EASD — the world's largest diabetes congress — as a #dedoc° voice. From new technological developments to global access, diabetes stigma to mental health, Mark recaps his learnings from the conference in this blog post.
Exploring cutting-edge insights from ATTD 2024: a journey into diabetes technology and management
“The recent ATTD 2024 conference was a beacon of innovation and insights into the realm of diabetes technology and management,” writes Tino in today’s recap of March’s scientific conference. “It is evident that we stand on the cusp of a new era in diabetes management.”